Project Financing Risk Assessment

Assessment Date: [DATE]

Assessor: [ASSESSOR NAME]

Department/Area: [DEPARTMENT/AREA]

Review Date: [REVIEW DATE]

1. Assessment Scope

This assessment covers the identification, analysis, evaluation, and control of risks associated with project financing activities across the project lifecycle, including origination, due diligence, structuring, approval, funding, covenant monitoring, refinancing, and close-out. It includes financial, regulatory, governance, operational, counterparty, market, liquidity, documentation, and compliance risks that may affect project viability, funding certainty, cost of capital, and repayment capacity. The assessment applies to internal project sponsors, finance teams, legal and compliance functions, procurement interfaces, lenders, advisors, and key contractors where their actions influence financing outcomes. Exclusions: this assessment does not replace detailed legal, tax, accounting, or credit committee reviews, nor does it assess construction-site physical safety hazards except where they directly affect financing risk through delay, cost overrun, or contractual non-compliance.

2. Risk Assessment Methodology

A structured qualitative risk assessment method is used, consistent with established risk assessment practice: hazards are identified, the likelihood and severity of harm are evaluated, and risks are prioritized for action. The assessment uses a 5x5-style qualitative matrix with defined likelihood levels (Rare, Unlikely, Possible, Likely, Almost Certain) and severity levels (Negligible, Minor, Moderate, Major, Catastrophic), resulting in overall ratings of Low, Medium, High, or Extreme. Controls are selected using the hierarchy of controls principle adapted to financial risk management: eliminate avoidable exposure, substitute lower-risk structures, apply engineering/system controls through process design and automation, implement administrative controls through governance and procedures, and use protective measures such as insurance, guarantees, and contractual safeguards. The assessment also considers normal operations and foreseeable non-routine events such as market shocks, covenant breaches, regulatory changes, refinancing stress, and counterparty failure.

3. Risk Matrix Reference

The following matrix is used to evaluate risk levels based on likelihood and severity:

		Likelihood
Rare	Unlikely	Possible	Likely	Almost Certain
Severity	Catastrophic	Low	Low	Low	Medium	Medium
Major	Low	Low	Medium	Medium	High
Moderate	Low	Medium	Medium	High	High
Minor	Medium	Medium	High	High	Extreme
Negligible	Medium	High	High	Extreme	Extreme

4. Hazard Identification and Risk Evaluation

1. Inaccurate financial modelling, assumptions, or sensitivity analysis leading to an overstatement of project returns or debt service capacity.

Potential Consequences: The project may be approved on unrealistic assumptions, resulting in funding shortfalls, covenant breaches, inability to service debt, delayed completion, or loss of investor confidence.

Affected Persons: Project sponsors, lenders, investors, finance teams, and governance committees.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Major	High

Control Measures

• Eliminate avoidable assumptions by using verified source data and conservative base cases.
• Substitute single-point estimates with scenario analysis and stress testing.
• Use engineering/system controls such as model validation, version control, and automated checks for formula integrity.
• Apply administrative controls including independent review, approval thresholds, and documented assumption governance.
• Require appropriate professional review and decision-maker sign-off before funding approval.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Unlikely	Major	Medium

2. Insufficient due diligence on counterparties, contractors, offtakers, or sponsors resulting in hidden credit, legal, or performance weaknesses.

Potential Consequences: Counterparty default, contract disputes, delayed payments, unenforceable security, or failure of key project obligations may occur, increasing financing losses and recovery time.

Affected Persons: Lenders, investors, sponsors, legal teams, procurement teams, and project management personnel.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Major	High

Control Measures

• Eliminate counterparties that do not meet minimum credit, legal, or compliance criteria.
• Substitute higher-risk counterparties with stronger entities where feasible.
• Use engineering/system controls such as due diligence checklists, document repositories, and automated compliance screening.
• Implement administrative controls including enhanced review for high-risk counterparties, escalation rules, and legal enforceability checks.
• Use contractual protections such as guarantees, step-in rights, collateral, and performance bonds where appropriate.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Unlikely	Major	Medium

3. Interest rate, inflation, foreign exchange, or commodity price volatility affecting project cash flow and debt affordability.

Potential Consequences: Debt service coverage may deteriorate, financing costs may rise, project margins may compress, and refinancing may become unavailable or more expensive.

Affected Persons: Project sponsors, treasury teams, lenders, investors, and beneficiaries of project outputs.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Likely	Major	Extreme

Control Measures

• Eliminate unnecessary exposure by matching currency and debt denomination where possible.
• Substitute variable-rate exposure with fixed-rate or hedged structures when commercially viable.
• Use engineering/system controls such as treasury limits, exposure dashboards, and automated covenant forecasting.
• Apply administrative controls including hedge policy, approval limits, and regular market monitoring.
• Use protective instruments such as hedging, reserves, liquidity buffers, and insurance where applicable.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Major	High

4. Regulatory, legal, tax, sanctions, anti-bribery, or permitting non-compliance affecting financing approval or ongoing funding conditions.

Potential Consequences: Regulatory penalties, delayed approvals, funding suspension, unenforceable agreements, reputational damage, or forced restructuring may result.

Affected Persons: Sponsors, lenders, compliance teams, legal counsel, regulators, and project stakeholders.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Catastrophic	Extreme

Control Measures

• Eliminate non-compliant structures before approval through early legal and regulatory screening.
• Substitute high-risk jurisdictions or structures with lower-risk compliant alternatives where feasible.
• Use engineering/system controls such as compliance registers, obligation tracking, and automated deadline alerts.
• Implement administrative controls including regulatory horizon scanning, legal review, and mandatory escalation of breaches.
• Maintain documentary evidence of permits, approvals, certifications, and compliance attestations.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Unlikely	Major	High

5. Weak governance, unclear authority, or poor segregation of duties leading to unauthorized commitments or poor decision-making.

Potential Consequences: Unauthorized financing commitments, fraud, conflicts of interest, delayed approvals, or poor capital allocation may occur.

Affected Persons: Executives, finance staff, board members, auditors, investors, and project sponsors.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Major	High

Control Measures

• Eliminate ambiguous approval pathways by defining decision rights and delegated authorities.
• Substitute informal approvals with formal governance forums and documented committee decisions.
• Use engineering/system controls such as workflow approvals, access restrictions, and audit trails.
• Apply administrative controls including conflict-of-interest declarations, segregation of duties, and periodic governance reviews.
• Use independent oversight through internal audit, compliance review, or external assurance where warranted.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Unlikely	Moderate	Medium

6. Liquidity shortfall or funding delay during construction, ramp-up, or refinancing periods.

Potential Consequences: Work stoppage, delayed supplier payments, breach of covenants, increased financing costs, insolvency risk, or project failure may occur.

Affected Persons: Project sponsors, contractors, suppliers, lenders, employees, and end users.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Likely	Major	Extreme

Control Measures

• Eliminate avoidable timing gaps by aligning funding milestones with expenditure profiles.
• Substitute single-source funding with diversified funding sources where feasible.
• Use engineering/system controls such as cash flow forecasting tools, drawdown trackers, and covenant monitoring dashboards.
• Implement administrative controls including minimum liquidity thresholds, contingency approvals, and monthly treasury reviews.
• Maintain contingency reserves, standby facilities, and refinancing plans.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Major	High

7. Cost overrun, schedule delay, or scope change increasing financing needs beyond approved limits.

Potential Consequences: Additional equity injections, debt restructuring, covenant pressure, reduced returns, or project cancellation may result.

Affected Persons: Sponsors, lenders, contractors, investors, and project governance bodies.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Likely	Major	Extreme

Control Measures

• Eliminate uncontrolled scope growth through strict change control.
• Substitute optimistic estimates with contingency-based budgets and conservative schedules.
• Use engineering/system controls such as integrated project controls, earned value tracking, and automated variance reporting.
• Apply administrative controls including change approval boards, milestone reviews, and escalation triggers.
• Use contractual protections such as liquidated damages, performance guarantees, and contingency allowances.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Possible	Major	High

8. Fraud, corruption, misrepresentation, or document falsification during financing origination or drawdown.

Potential Consequences: Misallocated funds, legal exposure, loss of lender confidence, regulatory action, and reputational damage may occur.

Affected Persons: Finance teams, sponsors, lenders, auditors, regulators, and counterparties.

Initial Risk Assessment

Likelihood	Severity	Risk Rating
Unlikely	Catastrophic	High

Control Measures

• Eliminate opportunities for single-person control over critical transactions.
• Substitute manual-only processes with controlled digital workflows and verification steps.
• Use engineering/system controls such as segregation of duties, dual authorization, and immutable audit logs.
• Implement administrative controls including ethics training, whistleblowing channels, and periodic fraud risk reviews.
• Use independent audits and transaction verification before disbursement.

Residual Risk Assessment

Likelihood	Severity	Risk Rating
Rare	Major	Medium

5. General Control Measures

• Establish a formal risk governance framework for project financing decisions.

Define risk appetite, approval thresholds, escalation routes, and reporting lines so that material risks are reviewed by competent decision-makers before commitments are made.

• Maintain a live risk register and action tracker throughout the financing lifecycle.

Record each material risk, owner, due date, control status, and residual risk rating; update after key milestones, incidents, or market changes.

• Require independent review of critical assumptions, legal terms, and financial models.

Use separate reviewers for modelling, legal, compliance, and treasury assumptions to reduce bias and detect errors before approval.

• Implement document control and evidence retention for all financing decisions.

Store executed agreements, approvals, due diligence outputs, covenant certificates, and compliance evidence in a controlled repository with version history.

• Maintain contingency planning and recovery options.

Prepare fallback funding sources, reserve policies, covenant cure options, and restructuring playbooks for adverse market or project conditions.

6. Emergency Preparedness

• If a material covenant breach, funding failure, or liquidity crisis is identified, escalate immediately to senior management, treasury, legal, and the relevant governance committee. Freeze non-essential commitments, quantify exposure, and activate the contingency funding plan. [2] [8]
• If regulatory non-compliance, sanctions exposure, or permit failure is discovered, suspend affected transactions until legal review is completed and corrective actions are approved. Notify required internal and external stakeholders according to jurisdictional obligations. [4] [1]
• If fraud, corruption, or document tampering is suspected, preserve records, restrict access, notify compliance and internal audit, and initiate an investigation before any further disbursement or approval. [1] [8]
• If market conditions deteriorate sharply, activate stress-test scenarios, reassess debt service capacity, and consider hedging adjustments, capital injections, or refinancing alternatives. [5] [7]

7. Training Requirements

• Project Finance Risk Awareness: Personnel involved in financing decisions should understand the project lifecycle risks that can affect funding, repayment, and compliance. Training should cover risk identification, escalation expectations, and the importance of documenting assumptions and decisions.
  • Recognize early warning signs of funding stress.
  • Understand the difference between inherent and residual risk.
  • Know when to escalate material issues to governance bodies.
• Financial Modelling and Assumption Control: Finance staff and reviewers should be trained to build, challenge, and validate financial models, including sensitivity analysis, scenario testing, and version control. Training should emphasize conservative assumptions and independent review.
  • Validate source data before use.
  • Test downside scenarios and covenant headroom.
  • Document model changes and approvals.
• Due Diligence and Compliance Review: Relevant staff should be trained to perform structured due diligence on counterparties, contracts, permits, and regulatory obligations. Training should include red flags for fraud, sanctions, anti-bribery, and legal enforceability issues.
  • Use standardized due diligence checklists.
  • Escalate adverse findings promptly.
  • Retain evidence of review and approval.
• Governance, Delegation, and Segregation of Duties: Managers and approvers should be trained on delegated authority limits, conflict-of-interest controls, and segregation of duties to prevent unauthorized commitments and reduce fraud risk.
  • Confirm approval authority before signing.
  • Separate preparation, review, and approval roles.
  • Record decisions in formal governance minutes.
• Contingency and Crisis Response: Key personnel should be trained on contingency funding plans, breach response, and communication protocols so that the organization can respond quickly to liquidity shocks, covenant breaches, or regulatory events.
  • Know the trigger points for escalation.
  • Understand the sequence for activating backup funding.
  • Practice response through tabletop exercises.

8. Monitoring and Review

Review Frequency: Annually and after any material incident, major project change, regulatory change, covenant breach, or significant market event.

Monitoring Type	Frequency	Responsible Party	Description
Regular Review	Monthly	Finance Manager / Treasury Lead	Review cash flow forecasts, covenant headroom, funding drawdowns, and key assumptions to identify emerging liquidity or affordability issues early.
Compliance Monitoring	Monthly and upon regulatory change	Compliance Officer / Legal Counsel	Track permits, approvals, sanctions exposure, legal obligations, and filing deadlines to ensure financing conditions remain satisfied.
Governance Audit	Quarterly	Internal Audit / Risk Committee	Verify that approvals, segregation of duties, and escalation procedures are being followed and that material decisions are properly documented.
Counterparty Review	At onboarding and annually thereafter	Procurement / Legal / Credit Risk Team	Reassess counterparty creditworthiness, performance history, beneficial ownership, and contractual compliance for material suppliers, contractors, and offtakers.
Stress Testing and Scenario Analysis	Quarterly and after major market events	Treasury / Financial Planning and Analysis	Re-run downside scenarios for interest rates, exchange rates, inflation, delays, and cost overruns to confirm the project remains financeable under adverse conditions.

9. Special Circumstances

• Market volatility, interest rate shocks, inflation spikes, or currency movements can rapidly increase financing costs and reduce debt service capacity, requiring immediate reassessment of exposure and hedging effectiveness. [3]
• Lone work, remote work, or off-site project activity can delay escalation of financing issues and reduce oversight, so additional communication and approval controls are required. [6] [9]
• Non-routine events such as shutdowns, power outages, emergencies, or extreme weather may disrupt project delivery, delay funding milestones, and trigger covenant or liquidity stress. [2] [5]
• Changes in legislation, standards, organizational policy, or stakeholder expectations can alter the risk profile and require reassessment before proceeding with funding decisions. [4] [1]

Approval and Sign-off

This risk assessment has been reviewed and approved by:

Assessor: _________________________ Date: __________

Manager/Supervisor: _________________________ Date: __________

Safety Representative: _________________________ Date: __________

This risk assessment must be reviewed annually and after any material incident, major project change, regulatory change, covenant breach, or significant market event. or when significant changes occur.

Safety powered by SALUS